Pawtucket
Pawtucket
Pawtucket, Rhode Island, United States10 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia | B-cell chronic lymphocytic leukemia, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 3 | 2026-10-01 | NCT01886872 | |
| Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Stomatognathic Diseases, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, lymphoid interstitial pneumonia, mouth disorder, neoplasm, salivary gland cancer, salivary gland disorder, salivary gland squamous cell carcinoma, squamous cell carcinoma, tongue cancer, tongue carcinoma, tongue disorder | Active, not recruiting | Phase 3 | 2026-10-01 | NCT00588770 | |
| Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast adenocarcinoma, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2026-10-01 | NCT00310180 | |
| AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy. | Stage IB-IIIA Non-small Cell Lung Carcinoma | Active, not recruiting | Phase 3 | 2026-09-11 | NCT02511106 | |
| Substance Use Prevention for Youth With Parents in Recovery | Chemically-Induced Disorders, Substance Use Disorders, psychiatric disorder, substance-related disorder | Active, not recruiting | Not applicable | 2026-08-06 | NCT05397691 | |
| Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma | DS Stage I Multiple Myeloma; DS Stage II Multiple Myeloma; DS Stage III Multiple Myeloma | Active, not recruiting | Phase 3 | 2026-07-29 | NCT00644228 | |
| Implementing Contingency Management for Stimulant Use in Specialty Addiction Treatment Organizations | Chemically-Induced Disorders, Narcotic-Related Disorders, Pathologic Processes, Pathological Conditions, Signs and Symptoms, disease, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2026-05-01 | NCT05702021 | |
| PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes | ASCVD; Type2Diabetes | Recruiting | Phase 4 | 2026-04-13 | NCT05390892 | |
| Rhode Island Community-based Maternal Support Services | Health Disparity, Minority and Vulnerable Populations; Perinatal Outcomes; Pregnancy; Social Determinants of Health (SDOH) | Recruiting | Not applicable | 2026-03-03 | NCT07446374 | |
| Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT) | Frailty, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cancer, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, depressive disorder, heart disorder, neoplasm, nervous system disorder, psychiatric disorder, stroke disorder, vascular disorder | Active, not recruiting | Not stated | 2025-11-04 | NCT07224347 |